Worldquant Millennium Advisors LLC Neurocrine Biosciences Inc Transaction History

Worldquant Millennium Advisors LLC

$8.06 Billion
Q1 2024

A detailed history of Worldquant Millennium Advisors LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Worldquant Millennium Advisors LLC holds 69,461 shares of NBIX stock, worth $9.56 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

69,461

Previous 18,695 271.55%

Holding current value

$9.56 Million

Previous $2.46 Million 288.96%

% of portfolio

0.12%

Previous 0.03%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$130.4 - $143.74 $6.62 Million - $7.3 Million	50,766 Added 271.55%	69,461 $9.58 Million
Q4 2023 Feb 14, 2024	SELL	$106.07 - $132.76 $321,498 - $402,395	-3,031 Reduced 13.95%	18,695 $2.46 Million
Q3 2023 Nov 14, 2023	SELL	$94.02 - $117.1 $9.16 Million - $11.4 Million	-97,430 Reduced 81.77%	21,726 $2.44 Million
Q2 2023 Aug 14, 2023	SELL	$89.53 - $104.87 $13.4 Million - $15.6 Million	-149,155 Reduced 55.59%	119,156 $11.2 Million
Q1 2023 May 15, 2023	BUY	$94.11 - $123.02 $1.62 Million - $2.12 Million	17,239 Added 6.87%	268,311 $27.2 Million

Q4 2022 Feb 14, 2023	BUY	$106.72 - $127.06 $17.1 Million - $20.4 Million	160,466 Added 177.1%	251,072 $30 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $8.34 Million - $9.77 Million	90,606 New	90,606 $9.62 Million
Q3 2020 Nov 16, 2020	SELL	$96.16 - $135.15 $9.9 Million - $13.9 Million	-103,004 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $2.62 Million - $4.01 Million	-30,740 Reduced 22.98%	103,004 $12.6 Million
Q1 2020 May 14, 2020	BUY	$75.11 - $113.76 $9.63 Million - $14.6 Million	128,234 Added 2327.3%	133,744 $11.6 Million
Q4 2019 Feb 14, 2020	BUY	$86.8 - $118.57 $478,268 - $653,320	5,510 New	5,510 $592,000

Others Institutions Holding NBIX

# of Institutions

628

Shares Held

94.4M

Call Options Held

505K

Put Options Held

343K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.2B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Worldquant Millennium Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worldquant Millennium Advisors LLC with notifications on news.

Account

Worldquant Millennium Advisors LLC Neurocrine Biosciences Inc Transaction History